Apraclonidine Ophthalmic (Akorn Inc.)


Welcome to the PulseAid listing for the Apraclonidine Ophthalmic drug offered from Akorn Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn Inc.
NON-PROPRIETARY NAME: Apraclonidine Hydrochloride
SUBSTANCE NAME: APRACLONIDINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-08-12
END MARKETING DATE: 0000-00-00


Apraclonidine Ophthalmic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionApraclonidine Ophthalmic from Akorn Inc.
LABELER NAME: Akorn Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2009-08-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-716_755eee9a-5377-40af-b98e-51a1ce669c9e
PRODUCT NDC: 17478-716
APPLICATION NUMBER: ANDA077764

Other APRACLONIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn Inc.Apraclonidine Ophthalmic
Alcon Laboratories, Inc.IOPIDINE
Sandoz Inc.Apraclonidine